During the past decade, Stedman Clinical Trials conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 43 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 24 clinical trials were completed. i.e. 141.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stedman Clinical Trials" #1 sponsor was "Cephalon" with 8 trials, followed by "Pfizer" with 8 trials sponsored, "Eli Lilly and Company" with 6 trials sponsored, "Shire" with 5 trials sponsored and "Biogen" with 5 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 50 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stedman Clinical Trials" #1 collaborator was "Pfizer" with 4 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "APCER Life Sciences" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Covance" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Stedman Clinical Trials" are "Alzheimer's Disease" (18 trials), "Alzheimer Disease" (14 trials), "Major Depressive Disorder" (9 trials), "Osteoarthritis" (5 trials) and "Chronic Pain" (4 trials). Many other conditions were trialed in "Stedman Clinical Trials" in a lesser frequency.

Most popular intervention types in "Stedman Clinical Trials" are "Drug" (92 trials), "Other" (5 trials), "Biological" (3 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (44 trials), "placebo" (6 trials), "Donanemab" (3 trials), "200 mg linzagolix tablet" (2 trials) and "75 mg linzagolix tablet" (2 trials). Other intervention names were less common.

The vast majority of trials in "Stedman Clinical Trials" are 88 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Stedman Clinical Trials". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 59 completed trials in Stedman Clinical Trials, 1 suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Stedman Clinical Trials, 1 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 3 trials that are defined as “Not Applicable".